Mantle cell lymphoma: a biological and therapeutic paradigm. - Wikidata - wikimedia - TriplyDB

Mantle cell lymphoma: a biological and therapeutic paradigm.

Mantle cell lymphoma: a biological and therapeutic paradigm.

http://www.wikidata.org/entity/Q34769876

about

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.Role of fludarabine in hematological malignancies.Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.Plasma-based testing as a new paradigm for clinical testing in hematologic diseases.Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma.Characterization of genetic changes in MCL by interphase FISH on tissue sections.

P2860

Q34563164-0A174018-B651-47F5-9626-19F104B7D73E Q34571439-A365691A-FBC9-4EB5-9613-E028E2E4EB23 Q34983013-C4BFA56A-3988-48E2-BEEE-483B0F8B4B17 Q36315020-7B762FBF-9CE3-4F88-BDBB-973DEA66DE74 Q36950447-0EC6E617-5C5E-4BC0-B408-7638B050CB60 Q41241688-F20C8892-3FC2-40F4-9B2A-A411F4C2AD16 Q53542728-9BCF7C25-76BC-4E08-B6B2-D3A19C8D9DE8

P2860

Mantle cell lymphoma: a biological and therapeutic paradigm.

http://www.wikidata.org/entity/Q34769876

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mantle cell lymphoma: a biological and therapeutic paradigm.

@ast

Mantle cell lymphoma: a biological and therapeutic paradigm.

@en

Mantle cell lymphoma: a biological and therapeutic paradigm.

@nl

type

label

Mantle cell lymphoma: a biological and therapeutic paradigm.

@ast

Mantle cell lymphoma: a biological and therapeutic paradigm.

@en

Mantle cell lymphoma: a biological and therapeutic paradigm.

@nl

prefLabel

Mantle cell lymphoma: a biological and therapeutic paradigm.

@ast

Mantle cell lymphoma: a biological and therapeutic paradigm.

@en

Mantle cell lymphoma: a biological and therapeutic paradigm.

@nl

P1433

Q34769876-BDD68585-302A-4C41-93EE-FA24898AA48F

P1476

Q34769876-8073793B-A42A-44AE-8BB4-F3CDC11BE2FC

P2093

Q34769876-DB5CE853-9C7A-4B62-99EE-B919AAFAF7C3

P2860

Q34769876-050274AC-210D-4B99-BB24-7C920AFC1B5D

Q34769876-155F0D14-7A39-4EAF-8F9E-57156592F717

Q34769876-1D44B6E9-F299-4C1B-8CB3-7955B74C4C28

Q34769876-253C3621-C5D1-429A-B233-21230FBCF741

Q34769876-305B4A63-5EA1-4D49-A661-CB52B96FA8FB

Q34769876-31C81E30-3CD1-4E40-B778-C688E6CC015C

Q34769876-365772FB-D23A-4EB2-8179-2004717D2C77

Q34769876-4123FFF0-4B2A-4890-8302-3AAAC1609315

Q34769876-451093CA-A02B-40A0-854C-E7719922D0E0

Q34769876-4AEA830B-BFC9-4BD7-910C-C64BB9B6F27D

P304

Q34769876-C8B6C5E2-E838-43BC-8755-62D1FE27B4CA

P31

Q34769876-4C6F96A1-CF63-4FBA-BD97-B21CAB6216EC

P356

Q34769876-20C5DBF0-89E7-4A96-BBA4-FFE54B6349D6

P433

Q34769876-731A73DE-F625-437B-BCF4-0314CFAADF01

P478

Q34769876-102B2980-1A37-44DE-A9B1-CA640753759A

P577

Q34769876-4628BDCF-5914-4638-ABD3-5C6E8A330BA3

P698

Q34769876-13FAFAEF-94F4-41E7-84DB-7FEECD11FDAE

P356

10428190290016881

P1433

Leukemia & Lymphoma

P1476

Mantle cell lymphoma: a biological and therapeutic paradigm.

@en

P2093

Didier Decaudin

http://www.w3.org/2001/XMLSchema#string

P2860

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

Interaction between ATM protein and c-Abl in response to DNA damage

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma

Enhanced phosphorylation of p53 by ATM in response to DNA damage

Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.

Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma.

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.

Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

P304

773-781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190290016881

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12153164

http://www.w3.org/2001/XMLSchema#string